NCT01138475View on ClinicalTrials.gov

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Gastric BypassParathyroid Hormone
Interventions
DRUG

Paricalcitol

1 microgram by mouth daily for 6 weeks

DRUG

Cholecalciferol

5000 IU (international units) by mouth daily for 6 weeks

DRUG

Placebo

Inactive substance, one capsule daily for 6 weeks

Trial Locations (1)

48073

William Beaumont Health Center, Royal Oak

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Kerstyn C. Zalesin, M.D.

OTHER